Stock data

中化控股 (3716)

中化控股 is a TWSE-listed company in Biotech & Medical Care. Revenue for September 2026 was NT$674.89M, down 11.0% from a year earlier. EPS over the last four quarters totals NT$4.10.

Charts, drawing tools, and the P/E calculator are in the app, free to use.

Open 中化控股 in Insightr